Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 May;153(5):789-803.e2.
doi: 10.1016/j.ajo.2011.10.026. Epub 2012 Jan 15.

Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up

Steven J Gedde  1 , Joyce C Schiffman, William J Feuer, Leon W Herndon, James D Brandt, Donald L Budenz; Tube versus Trabeculectomy Study Group
Affiliations
Randomized Controlled Trial

Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up

Steven J Gedde et al. Am J Ophthalmol. 2012 May.

Abstract

Purpose: To report 5-year treatment outcomes in the Tube Versus Trabeculectomy (TVT) Study.

Design: Multicenter randomized clinical trial.

Settings: Seventeen clinical centers.

Study population: Patients 18 to 85 years of age who had previous trabeculectomy and/or cataract extraction with intraocular lens implantation and uncontrolled glaucoma with intraocular pressure (IOP) ≥18 mm Hg and ≤40 mm Hg on maximum tolerated medical therapy.

Interventions: Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C ([MMC]; 0.4 mg/mL for 4 minutes).

Main outcome measures: IOP, visual acuity, use of supplemental medical therapy, and failure (IOP >21 mm Hg or not reduced by 20%, IOP ≤5 mm Hg, reoperation for glaucoma, or loss of light perception vision).

Results: A total of 212 eyes of 212 patients were enrolled, including 107 in the tube group and 105 in the trabeculectomy group. At 5 years, IOP (mean ± SD) was 14.4 ± 6.9 mm Hg in the tube group and 12.6 ± 5.9 mm Hg in the trabeculectomy group (P = .12). The number of glaucoma medications (mean ± SD) was 1.4 ± 1.3 in the tube group and 1.2 ± 1.5 in the trabeculectomy group (P = .23). The cumulative probability of failure during 5 years of follow-up was 29.8% in the tube group and 46.9% in the trabeculectomy group (P = .002; hazard ratio = 2.15; 95% confidence interval = 1.30 to 3.56). The rate of reoperation for glaucoma was 9% in the tube group and 29% in the trabeculectomy group (P = .025).

Conclusions: Tube shunt surgery had a higher success rate compared to trabeculectomy with MMC during 5 years of follow-up in the TVT Study. Both procedures were associated with similar IOP reduction and use of supplemental medical therapy at 5 years. Additional glaucoma surgery was needed more frequently after trabeculectomy with MMC than tube shunt placement.

Trial registration: ClinicalTrials.gov NCT00306852.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of patient progress in the Tube Versus Trabeculectomy Study.
Figure 2
Figure 2
Intraocular pressure (IOP) at baseline and follow-up in the Tube Versus Trabeculectomy Study. Data are presented as mean ± standard error of the mean and are censored after a reoperation for glaucoma.
Figure 3
Figure 3
Kaplan-Meier plots of the probability of failure in the Tube Versus Trabeculectomy Study.
Figure 4
Figure 4
Kaplan-Meier plots of the cumulative probability of failure in the Tube Versus Trabeculectomy Study defining inadequate intraocular (IOP) reduction as IOP > 17 mm Hg or not reduced by 20% below baseline (left) or IOP > 14 mm Hg (right). Inadequate IOP reduction criteria must have been present on 2 consecutive visits after 3 months to qualify as failure. Patients with persistent hypotony, reoperation for glaucoma, and loss of light perception vision are classified as failures.
Figure 5
Figure 5
Distribution of change in visual acuity from baseline to the 5-year follow-up visit in the Tube Versus Trabeculectomy Study.
See this image and copyright information in PMC

Comment in

References

    1. Minckler D, Mosaed S, Dustin L, Francis B Trabectome Study Group. Trabectome (trabeculectomy-internal approach): Additional experience and extended follow-up. Trans Am Ophthalmol Soc. 2008;106:149–159. - PMC - PubMed
    1. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: Circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: Two year interim clinical study. J Cataract Refract Surg. 2009;35(5):814–824. - PubMed
    1. Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: A pilot study. Arch Ophthalmol. 2009;127(3):264–269. - PubMed
    1. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. - PubMed
    1. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114(12):2265–2270. - PubMed

Publication types

MeSH terms

Associated data